This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation. This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.
Study Type
OBSERVATIONAL
Enrollment
81
Previous studies did not question why patients thought they did not benefit from the injection. For example, the expectations of patients who said they did not benefit were excessive.
Süleyman Demirel University Faculty of Medicine Hospital
Isparta, Turkey (Türkiye)
Primary Outcome
Most PSS patients received only one BoNT-A injection over 12 years
Time frame: 2012-2024
Primary Outcome
The primary reason cited for discontinuing BoNT-A therapy was a lack of awareness about the necessity of ongoing treatment.
Time frame: 2012-2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.